TECH Signal 334
Low-dose digoxin cuts heart-failure hospitalizations by 25% in meta-analysis
↗
Low-dose digoxin added to standard heart-failure care cut hospitalizations by about 25% in a meta-analysis of three studies, suggesting the cheap drug could return to broader use.
For engineers building clinical decision support or treatment protocols, this is a low-cost intervention with a large effect on a common, expensive outcome. The finding that digoxin works even on top of the 'Fantastic Four' standard regimen changes the optimization problem for heart-failure care. The drug's low price and safety profile could make it a default addition, affecting hospital readmission metrics and care pathways.
Written by elseif from the cluster below · every claim links back to a sourceThe three things worth knowing
Low-dose digoxin reduced heart-failure hospitalizations by an average of 25% in a meta-analysis of three studies.
The drug costs less than ten cents per day and was found safe when added to the four standard heart-failure medications.
A third study found that stopping digoxin led to significantly more problems in the first six weeks, suggesting a rebound effect.
THE CLUSTER